The effect of zanamivir treatment on the early immune response to influenza vaccinationCOX, Rebecca J; MYKKELTVEDT, Eva; SJURSEN, Hakon et al.Vaccine. 2001, Vol 19, Num 32, pp 4743-4749, issn 0264-410XArticle

Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4⁺ cells and strong antibody responses in miceMADHUN, Abdullah S; HAAHEIM, Lars R; NILSEN, Mona V et al.Vaccine. 2009, Vol 27, Num 52, pp 7367-7376, issn 0264-410X, 10 p.Article

Haemagglutination-inhibiting antibody to influenza virusDE JONG, J. C; PALACHE, A. M; BEYER, W. E et al.Developments in biologicals. 2003, Vol 115, pp 63-73, issn 1424-6074, 11 p.Conference Paper

Immune correlates of protection against influenza in the human challenge modelTREANOR, J; WRIGHT, R. F.Developments in biologicals. 2003, Vol 115, pp 97-104, issn 1424-6074, 8 p.Conference Paper

Antigen-independent activation of resting T-cells in the liver of patients with chronic hepatitisABRIGNANI, S.Developments in biological standardization. 1998, Num 92, pp 191-194, issn 0301-5149Conference Paper

Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of A group B Neisseria meningitidis outer membrane vesicle vaccineROSENQVIST, E; HØIBY, E. A; FRØHOLM, L. O et al.Developments in biological standardization. 1998, Num 92, pp 323-333, issn 0301-5149Conference Paper

Induction of virus-specific immunity by iscomsOSTERHAUS, A. D. M. E; RIMMELZWAAN, G. F.Developments in biological standardization. 1998, Num 92, pp 49-58, issn 0301-5149Conference Paper

Overview of the WHO Global Influenza ProgrammeSTÖHR, K.Developments in biologicals. 2003, Vol 115, pp 3-8, issn 1424-6074, 6 p.Conference Paper

The use of correlates of immunity in European Union licensing of Influenza vaccinesWOOD, J. M; NEWMAN, R. W; PLOSS, K et al.Developments in biologicals. 2003, Vol 115, pp 9-16, issn 1424-6074, 8 p.Conference Paper

Immune responses against hepatitis C virus structural proteins following genetic immunisationINCHAUSPE, G; MAJOR, M. E; NAKANO, I et al.Developments in biological standardization. 1998, Num 92, pp 163-168, issn 0301-5149Conference Paper

Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminantsMASLOG, F. S.Developments in biological standardization. 1998, Num 92, pp 301-307, issn 0301-5149Conference Paper

Iscom, a delivery system for parenteral and mucosal vaccinationMOREIN, B; VILLACRES-ERIKSSON, M; LÖVGREN-BENGTSSON, K et al.Developments in biological standardization. 1998, Num 92, pp 33-39, issn 0301-5149Conference Paper

Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheresWALKER, K. B; XING, D. K.-L; SESARDIC, D et al.Developments in biological standardization. 1998, Num 92, pp 259-267, issn 0301-5149Conference Paper

Systemic immunization with conserved pilus-associated adhesins protects against mucosal infectionsPALASZYNSKI, S; PINKNER, J; LEATH, S et al.Developments in biological standardization. 1998, Num 92, pp 117-122, issn 0301-5149Conference Paper

Original Antigenic sin: A confounding issue?HAAHEIM, L. R.Developments in biologicals. 2003, Vol 115, pp 49-53, issn 1424-6074, 5 p.Conference Paper

Current methods for assessing T cell responses to influenzaKATZ, J. M.Developments in biologicals. 2003, Vol 115, pp 85-93, issn 1424-6074, 9 p.Conference Paper

Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunizationDE MAGISTRIS, M. T; PIZZA, M; DOUCE, G et al.Developments in biological standardization. 1998, Num 92, pp 123-126, issn 0301-5149Conference Paper

Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheresGUPTA, R. K; GRIFFIN, P. JR; RIVERA, R et al.Developments in biological standardization. 1998, Num 92, pp 277-287, issn 0301-5149Conference Paper

In vitro determination of antigen quality : Biosensor analysis and fluorescence spectroscopyKERSTEN, G. F. A; JISKOOT, W; HAZENDONK, T et al.Developments in biological standardization. 1998, Num 92, pp 295-300, issn 0301-5149Conference Paper

Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares : Field trialBARRANDEGUY, M; PARRENO, V; LAGOS MARMOL, M et al.Developments in biological standardization. 1998, Num 92, pp 253-257, issn 0301-5149Conference Paper

Protective immunity to intracellular parasites : A focus for vaccine research and a challenge to immunization programmesHARBOE, M.Developments in biological standardization. 1998, Num 92, pp 145-147, issn 0301-5149Conference Paper

The mode of action of immunological adjuvantsALLISON, A. C.Developments in biological standardization. 1998, Num 92, pp 3-11, issn 0301-5149Conference Paper

Adjuvants in perspectiveVOGEL, F. R.Developments in biological standardization. 1998, Num 92, pp 241-248, issn 0301-5149Conference Paper

Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery systemCRYZ, S. J; GLÜCK, R.Developments in biological standardization. 1998, Num 92, pp 219-223, issn 0301-5149Conference Paper

Salivary immune responses after gingival immunization with tetravaccinal and bivaccinal formulations of inactivated micro-organismsCASETTA, P; NEGRETTI, F.Developments in biological standardization. 1998, Num 92, pp 317-321, issn 0301-5149Conference Paper